PDCD1 and neoplasm: Tumor‐infiltrating leukocytes were evaluated, and the gating strategy was shown in Fig. S8. The results showed an increased number of PD‐1+CD44+CD8+ T cells in tumors treated with the anti‐PD‐1 antibody, itraconazole, or both (Fig. 7B, left).